Author: Yi, Yang; Xu, Yanan; Jiang, Haibing; Wang, Jun
Title: Cardiovascular Disease and COVID-19: Insight From Cases With Heart Failure Cord-id: bymvcfxa Document date: 2021_3_15
ID: bymvcfxa
Snippet: Recent evidence indicates that a large proportion of deaths from coronavirus disease 2019 (COVID-19) can be attributed to cardiovascular disease, including acute myocardial infarction, arrhythmias and heart failure. Indeed, severe infection increases the risk of heart failure among patients with COVID-19. In most patients, heart failure arises from complex interactions between pre-existing conditions, cardiac injury, renin-angiotensin system activation, and the effects of systemic inflammation o
Document: Recent evidence indicates that a large proportion of deaths from coronavirus disease 2019 (COVID-19) can be attributed to cardiovascular disease, including acute myocardial infarction, arrhythmias and heart failure. Indeed, severe infection increases the risk of heart failure among patients with COVID-19. In most patients, heart failure arises from complex interactions between pre-existing conditions, cardiac injury, renin-angiotensin system activation, and the effects of systemic inflammation on the cardiovascular system. In this review, we summarize current knowledge regarding pathogen-driven heart failure occurring during treatment for COVID-19, the potential effects of commonly used cardiovascular and anti-infective drugs in these patients, and possible directions for establishing a theoretical basis for clinical treatment.
Search related documents:
Co phrase search for related documents- abdominal aortic aneurysm and ace inhibitor: 1, 2
- abdominal aortic aneurysm and activity expression: 1
- abdominal aortic aneurysm and acute myocardial infarction: 1, 2
- abdominal aortic aneurysm and acute pneumonia: 1
- abdominal aortic aneurysm and acute respiratory syndrome: 1, 2, 3, 4
- abdominal aortic aneurysm and acute sars cov respiratory syndrome coronavirus: 1, 2
- abdominal aortic aneurysm and lung injury: 1
- abnormal activation and acute respiratory infection: 1, 2
- abnormal activation and acute respiratory syndrome: 1, 2, 3, 4
- abnormal activation and acute sars cov respiratory syndrome coronavirus: 1, 2
- abnormal activation and lung heart: 1
- abnormal activation and lung injury: 1
Co phrase search for related documents, hyperlinks ordered by date